In my previous post, I promised this post would describe the minority of users whose lives are taken over by cannabis. Although less common, given how many people begin using cannabis during ...

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have revolutionized the treatment of obesity and type 2 diabetes. Medicines such as semaglutide (Ozempic and Wegovy) and tirzepatide ...

GLP-1 drugs, originally developed for diabetes and obesity, may also curb addictive behaviors by acting on reward circuits in the brain. Early trials show reductions in alcohol intake, opioid seeking, ...